Business
Medincell Announces the Appointment of Dr. Sharon Mates, Dr. Charles Kunsch, and Dr. Pascal Touchon to Its Board of Directors
MONTPELLIER, France, September 12, 2025--Regulatory News: Medincell (Paris:MEDCL) General Assembly held on September 11, 2025, has approved the appointments of three new independent board members: Dr Sharon Mates, Dr. Charles Kunsch, and Dr. Pascal Touchon.
About this update from Medincell Sa
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1772,"height":295,"url":"https://media.zenfs.com/en/business-wire.com/0a4c1af387e90fe899153cf3cac9a414"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LnNY_whIcPmU9Sn8o7wJpw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0a4c1af387e90fe899153cf3cac9a414","width":960,"height":160},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/pdh_XYPWuG4likstgNZ0rA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00MDA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/0a4c1af387e90fe899153cf3cac9a414","width":1200,"height":200}},"lazy":false},{"type":"text","content":"MONTPELLIER, France, September 12, 2025--(BUSINESS WIRE)--Regulatory News:","length":74,"tagName":"p"},{"type":"text","content":"Medincell (Paris:MEDCL) General Assembly held on September 11, 2025, has approved the appointments of three new independent board members: Dr Sharon Mates, Dr. Charles Kunsch, and Dr. Pascal Touchon.","length":199,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Dr. Sharon Mates, PhD, is the co-founder and former Chair and CEO of Intra-Cellular Therapies, a CNS-focused biotech that developed the successful drug CAPLYTA®, acquired by Johnson & Johnson for $14.6 billion in April 2025.","length":228,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Dr. Charles Kunsch, PhD, is a seasoned life sciences executive with over 30 years of experience, including as former Managing Director at AbbVie Ventures, where he led investments in pioneering biotech companies.","length":212,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Dr. Pascal Touchon, DVM, has over 40 years of international leadership in the biopharmaceutical industry, including key roles at Novartis Oncology and Atara Biotherapeutics and current board positions at Ipsen, CDR-Life, RoslinCT, Catalym and Xylocor.","length":251,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":691,"olType":false},{"type":"text","content":"Philippe Guy, Chairman of Medincell’s Board, said: "With the election of Dr. Sharon Mates, Dr. Charles Kunsch, and Dr. Pascal Touchon, we welcome a wealth of additional experience in innovation, strategic vision, and inf...